<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for PFE</title>
    <link />
    <description>Headlines for Pfizer</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Johnson &amp; Johnson Stock Checkup for May</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/20/johnson-johnson-stock-checkup-for-may/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 20 May 2013 18:34:00 GMT</pubDate>
    </item>
    <item>
      <title>Pfizer Discontinues Phase 3 Study of Inotuzumab Ozogamicin in Relapsed or Refractory Aggressive Non-</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/20/pfizer-discontinues-phase-3-study-of-inotuzumab-oz/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 20 May 2013 17:21:24 GMT</pubDate>
    </item>
    <item>
      <title>6 Healthy Products That Aren't</title>
      <link>http://www.fool.com/news/xt/minyanville/www.minyanville.com/sectors/consumer/articles/6-healthy-products-that-aren2527t-health/5/20/2013/id/49862.aspx</link>
      <author>Minyanville</author>
      <pubDate>Mon, 20 May 2013 14:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Medtronic Q4 Earnings: Modest Revenue Growth And Gross Margin Pressure Expected</title>
      <link>http://www.fool.com/news/xt/trefis/www.trefis.com/stock/mdt/articles/187072/medtronic-q4-earnings-modest-revenue-growth-and-gross-margin-pressure-expected/2013-05-20.aspx</link>
      <author>Trefis</author>
      <pubDate>Mon, 20 May 2013 11:44:07 GMT</pubDate>
    </item>
    <item>
      <title>Catalyst Pharmaceutical's CPP-115 May Be Big Pipeline In Just One Little Pill</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1447111-catalyst-pharmaceutical-s-cpp-115-may-be-big-pipeline-in-just-one-little-pill.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 20 May 2013 11:30:31 GMT</pubDate>
    </item>
    <item>
      <title>1 Pioneering Device to Jump-Start the Cardiovascular Industry</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/20/1-promising-device-to-jump-start-the-cardiovascula/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 20 May 2013 11:06:00 GMT</pubDate>
    </item>
    <item>
      <title>FDA Painkiller Abuse Concerns Creating Opportunity For Pfizer</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1446741-fda-painkiller-abuse-concerns-creating-opportunity-for-pfizer.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 20 May 2013 09:30:40 GMT</pubDate>
    </item>
    <item>
      <title>Allergan, Inc. (AGN) Ex-Dividend Date Scheduled for May 21, 2013</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/allergan-inc-agn-exdividend-date-scheduled-for-may-21-2013-cm247161.aspx</link>
      <author>Nasdaq</author>
      <pubDate>Mon, 20 May 2013 09:00:05 GMT</pubDate>
    </item>
    <item>
      <title>Tackling Cancer: Leukemia's Biggest Current and Upcoming Players</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/19/tackling-cancer-leukemias-biggest-current-upcoming/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Sun, 19 May 2013 18:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Oramed Sweeps Past Worldwide Giants With The First Trial Of Orally Delivered Insulin</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1445881-oramed-sweeps-past-worldwide-giants-with-the-first-trial-of-orally-delivered-insulin.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Sun, 19 May 2013 16:43:58 GMT</pubDate>
    </item>
    <item>
      <title>1 Great Dividend You Can Buy Right Now</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/19/1-great-dividend-you-can-buy-right-now-31/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Sun, 19 May 2013 16:30:00 GMT</pubDate>
    </item>
    <item>
      <title>The 3 Deadliest Diseases in the U.S.</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/19/the-3-deadliest-diseases-in-the-us/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Sun, 19 May 2013 14:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Statin Users May Have a Reason to Rejoice After This Data</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/19/statin-users-may-have-a-reason-to-rejoice-after-th/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Sun, 19 May 2013 12:05:00 GMT</pubDate>
    </item>
    <item>
      <title>Ask a Fool: Time to Sell These 3 Big Dividends?</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/19/ask-a-fool-time-to-sell-these-3-big-dividends/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Sun, 19 May 2013 11:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Will ASCO Unlock Big Value in This Cancer Drug Class?</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/18/will-asco-unlock-big-value-in-this-cancer-drug-cla/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 18 May 2013 14:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Pick Your Poison: Overweight or High Cholesterol</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/18/pick-your-poison-overweight-or-high-cholesterol/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 18 May 2013 11:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Why MannKind's Afrezza Will Succeed Where Pfizer Failed</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1444991-why-mannkind-s-afrezza-will-succeed-where-pfizer-failed.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Sat, 18 May 2013 04:45:03 GMT</pubDate>
    </item>
    <item>
      <title>Dow Jumps on Virtuous Cycle</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/17/dow-jumps-on-virtuous-cycle/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 17 May 2013 22:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Industrial Stocks Drive Dow’s 112-Point Day</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/17/industrial-stocks-drive-dows-112-point-day/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 17 May 2013 18:10:00 GMT</pubDate>
    </item>
    <item>
      <title>Market Close Report: NASDAQ Composite index closes at 3,498.97 up 33.73 points</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/market-close-report-nasdaq-composite-index-closes-at-349897-up-3373-points-cm247047.aspx</link>
      <author>Nasdaq</author>
      <pubDate>Fri, 17 May 2013 16:45:08 GMT</pubDate>
    </item>
  </channel>
</rss>
